How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

  • Question on Consultation

    Has all of the relevant evidence been taken into account?

  • Question on Consultation

    Are the summaries of clinical and cost effectiveness reasonable interpretations of the evidence?

  • Question on Consultation

    Are the recommendations sound and a suitable basis for guidance to the NHS?

  • Question on Consultation

    Are there any equality issues that need special consideration and are not covered in the medical technology consultation document?
The content on this page is not current guidance and is only for the purposes of the consultation process.

MEDICAL TECHNOLOGIES EVALUATION PROGRAMME

Closed for comments This consultation ended on at   Request commenting lead permission

4 Committee members and NICE project team

Committee members

This topic was considered by NICE's medical technologies advisory committee, which is a standing advisory committee of NICE.

Committee members are asked to declare any interests in the technologies to be evaluated. If it is considered there is a conflict of interest, the member is excluded from participating further in that evaluation.

The minutes of the medical technologies advisory committee meetings, which include the names of the members who attended and their declarations of interests, are posted on the NICE website.

Additional specialist committee members took part in the discussions and provided expert advice for this topic:

Specialist committee members

Dr Rob Hallifax
Consultant in respiratory medicine and senior research fellow, Oxford University NHS Foundation Trust, and University of Oxford

Ravijyot Saggu
Consultant respiratory pharmacist, Central London Community Healthcare Trust

Cheryl O'Sullivan
Advanced nurse practitioner, chief nursing information officer and clinical safety officer, NHS Dorset

David McLean
Patient expert

Rashmi Agrawal
Patient expert

NICE project team

Each medical technologies guidance topic is assigned to a team consisting of 1 or more health technology assessment analysts (who act as technical leads for the topic), a health technology assessment adviser and a project manager.

Aamer Jawed
Health technology assessment adviser (acting)

Haider Shamsi
Health technology assessment analyst

Amy Crossley
Health technology assessment adviser

Catherine Pank
Project manager

ISBN: